Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing

Baseline Platelet Count and Creatinine Clearance Rate Predict the Outcome of Neutropenia-Related Invasive Aspergillosis

(2012) S. A. Nouer et al.   CLINICAL INFECTIOUS DISEASES

Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil

(2012) M. Nucci et al.   CLINICAL MICROBIOLOGY AND INFECTION

Galactomannan testing might be useful for early diagnosis of fusariosis

(2012) Małgorzata Mikulska et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The role of antifungal treatment in hematology

(2012) J. A. Maertens et al.   HAEMATOLOGICA

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies

(2012) M. Reinwald et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

(2012) L. Y. A. Chai et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cross-reactivity in the Platelia™Aspergillusenzyme immunoassay caused by blastomycosis

(2012) Jon Van Der Veer et al.   MEDICAL MYCOLOGY

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

(2011) O Marchetti et al.   BONE MARROW TRANSPLANTATION

Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition

(2011) S. A. Nouer et al.   CLINICAL INFECTIOUS DISEASES

Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients

(2011) A. Bergeron et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay

(2011) A. M. Tortorano et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis

(2011) Elaine McCulloch et al.   JOURNAL OF CLINICAL PATHOLOGY

Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients

(2011) Sun Hee Park et al.   MYCOSES

Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel Therapies

(2010) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

(2010) S. Koo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

(2009) Johan Maertens et al.   CANCER

Serum Cross‐Reactivity withAspergillusGalactomannan and Cryptococcal Antigen during Fatal DisseminatedTrichosporon dermatisInfection

(2009) A. Fekkar et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance

(2008) Mine Durusu Tanriover et al.   MYCOSES